尤泓杰,王雍博,刘郅涵,等.MicroRNA-183通过结合LRIG1促进膀胱癌疾病进展的研究[J].肿瘤学杂志,2024,30(12):1023-1030. |
MicroRNA-183通过结合LRIG1促进膀胱癌疾病进展的研究 |
MicroRNA-183 Promotes Malignant Features of Bladder Cancer Cells Through Targeting LRIG1 |
投稿时间:2024-08-15 |
DOI:10.11735/j.issn.1671-170X.2024.12.B007 |
|
|
中文关键词: 膀胱肿瘤 微小RNA-183 亮氨酸丰富重复免疫球蛋白样域蛋白1 增殖 迁移 侵袭 凋亡 |
英文关键词:bladder neoplasms microRNA-183 leucine-rich repeats and immunoglobulin-like domains 1 proliferation migration invasion apoptosis |
基金项目:浙江省医药卫生科技计划项目(2021KY988) |
|
摘要点击次数: 139 |
全文下载次数: 28 |
中文摘要: |
浙江省医药卫生科技计划项目(2021KY988)摘 要:[目的] 探讨微小RNA-183(microRNA-183,miR-183)对膀胱癌(bladder cancer,BCa)疾病进展的影响及作用机制。[方法] 体外培养人BCa细胞株T24,分别/联合抑制细胞的miR-183和亮氨酸丰富重复免疫球蛋白样域蛋白1(leucine-rich repeats and immunoglobulin-like domains 1,LRIG1)的表达,将细胞分为对照(normal control,NC)、miR-183 inhibior、shLRIG1和miR-183 inhibitor+shLRIG1四组,qRT-PCR检测miR-183和LRIG1 mRNA的表达,Western blot检测细胞中LRIG1和表皮生长因子受体(epidermal growth factor receptor,EGFR)的蛋白表达水平;CCK-8、划痕实验、Transwell法及流式细胞术分别检测细胞增殖、迁移、侵袭及凋亡情况。[结果] 与NC组相比,miR-183敲减(miR-183 inhibior组)的T24细胞中LRIG1的表达增加而EGFR的表达降低(P<0.05),shLRIG1组中LRIG1表达降低而EGFR表达增加(P<0.05),shLRIG1+miR-183 inhibitor组逆转了单个因素敲减所导致的上述变化。此外,miR-183敲减后,T24细胞的增殖、迁移、侵袭水平降低而凋亡水平增加(P<0.05),shLRIG1组细胞的增殖、迁移、侵袭水平增加而凋亡水平降低(P<0.05),shLRIG1+miR-183 inhibitor组与NC组比较各项指标差异均无统计学意义。[结论] miR-183可能通过靶向结合LRIG1来调控膀胱癌细胞EGFR的表达,进而影响了膀胱癌细胞的生物学功能。 |
英文摘要: |
Abstract: [Objective] To investigate the effect and mechanism of microRNA-183 (miR-183) on biological features of bladder cancer (BCa) cells. [Methods] The exprssions of miR-183 and leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) were knocked down in human bladder cancer T24 cells. T24 cells were divided into 4 groups: NC group, miR-183 inhibior group, shLRIG1 group and miR-183 inhibitor+shLRIG1 group. The miR-183 and LRIG1 mRNA expressions were detected by qRT-PCR. The protein expressions of LRIGI and epidermal growth factor receptor (EGFR) were detected by Western blot. The cell proliferation, cell migration, cell invasion and apoptosis were detected by CCK-8, Scratch test, Transwell assay and flow cytometry, respectively. [Results] Compared with NC group, LRIG1 protein expression significantly increased and EGFR expression significantly decreased in the miR-183 inhibitor group (P<0.05), while LRIG1 protein expression significantly decreased and EGFR expression significantly increased in the shLRIG1 group (P<0.05); the shLRIG1+miR-183 inhibitor reversed the above changes. The cell proliferation, migration, invasion decreased, and the apoptosis increased in the miR-183 inhibitor group (P<0.05), while the cell proliferation, migration, and invasion increased, and the apoptosis decreased in the shLRIG1 group (P<0.05). There was no significant difference in the biological functions between the NC group and the shLRIG1+miR-183 inhibitor group. [Conclusion] MiR-183 may affect EGFR expression and regulate the bio-logical functions of bladder cancer cells through targeting LRIG1. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |